US Patent 11345654 Polymorphic compounds and uses thereof
Patent 11345654 was granted and assigned to Navitor Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Silvia Lenzini0
Edits on 28 Apr, 2023
Golden AI
Infobox
Edits on 2 Apr, 2023
Golden AI
Infobox
Edits on 24 Mar, 2023
Golden AI
Infobox
Edits on 21 Mar, 2023
Golden AI
Infobox
Edits on 26 Sep, 2022
Golden AI
Infobox
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113456540
Date of Patent
May 31, 2022
0Patent Application Number
166625170
Date Filed
October 24, 2019
0Patent Citations
Patent Primary Examiner
CPC Code
Golden AI
Infobox
Edits on 1 Jun, 2022
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+105 characters)
US Patent 11345654 Polymorphic compounds and uses thereof
Article
The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11345654
Date of patent
May 31, 2022
Patent application number
16662517
Date Filed
October 24, 2019
Patent citations
Patent primary examiner
CPC Code
Find more entities like US Patent 11345654 Polymorphic compounds and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
